Vieira Martins M, de Lorenzo P, Kotecha RS, Attarbaschi A, et al. Sustained Benefit of Blinatumomab in Infants With KMT2A-Rearranged ALL: Long-Term Outcomes, Toxicity, and Pharmacokinetics. J Clin Oncol 2026;44:370-374.
PMID: 41505662